21:00 , Jun 22, 2017 |  BC Innovations  |  Targets & Mechanisms

Exosomes deliver

Codiak BioSciences Inc. founder Raghu Kalluri has published the first animal data demonstrating exosomes can be used as drug delivery vehicles to treat cancer -- not just diagnose it. The findings also mark the unveiling...
07:00 , May 20, 2002 |  BC Week In Review  |  Clinical News

CA19-9 radioimmunoassay regulatory update

The FDA granted marketing approval to Fujirebio's Fujirebio Diagnostics Inc. division (Malvern, Penn.) for its CA19-9 radioimmunoassay to monitor serum CA 19-9 levels in pancreatic cancer patients to assess treatment effectiveness. Fujirebio Inc., Tokyo, Japan...